Physician profile
Deana E Paley
NPI 1942416771
$1,172.00
in general payments reported to CMS, 2019-2025
18 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $177 · 2022: $229 · 2023: $157 · 2024: $282 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $276.90 | 2022-2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $135.77 | 2021-2025 | Artiss |
| Edwards Lifesciences Corporation | $103.68 | 2021 | |
| Abbvie INC. | $80.64 | 2023-2025 | |
| Hydrofera LLC | $78.64 | 2022-2023 | Hydrofera Blue Ready - Border |
| Polynovo North America LLC | $75.79 | 2023-2025 | Novosorb Btm |
| Mimedx Group, INC. | $71.22 | 2024-2025 | |
| Axogen | $57.23 | 2024-2025 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Musculoskeletal Transplant Foundation INC. | $56.63 | 2022-2023 | |
| Pacira Pharmaceuticals Incorporated | $45.86 | 2022-2024 | Exparel |
| Convatec INC. | $32.87 | 2025 | |
| Integra Lifesciences Corporation | $28.39 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Solventum Corporation | $26.23 | 2025 | Prevena, V.A.C. Granufoam |
| Avita Medical Americas, LLC | $24.88 | 2025 | Cohealyx, Recell, Permeaderm |
| Tela Bio, INC. | $24.29 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $20.44 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $18.57 | 2023 | Seglentis |
| Smith+Nephew, INC. | $13.97 | 2023 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deana Paley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.